Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Blockade of lipid accumulation by silibinin in adipocytes and zebrafish

(2015) Hyung Joo Suh et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Silymarin Inhibits the Progression of Fibrosis in the Early Stages of Liver Injury in CCl4-Treated Rats

(2015) Simona Clichici et al.   JOURNAL OF MEDICINAL FOOD

Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes

(2015) Vasilios Papademetriou et al.   KIDNEY INTERNATIONAL

Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: A randomized, triple-blind, placebo-controlled clinical trial

(2015) Soraiya Ebrahimpour koujan et al.   PHYTOMEDICINE

Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?

(2013) E. Mannucci et al.   DIABETES CARE

Economic Costs of Diabetes in the U.S. in 2012

(2013)   DIABETES CARE

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

Effect of Addition of Silymarin to Renin-Angiotensin System Inhibitors on Proteinuria in Type 2 Diabetic Patients With Overt Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial

(2012) Mohammad Kazem Fallahzadeh et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes

(2011) Naeti Suksomboon et al.   JOURNAL OF ETHNOPHARMACOLOGY

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy

(2011) Juan F. Navarro-González et al.   Nature Reviews Nephrology

Silymarin protects PBMC against B(a)P induced toxicity by replenishing redox status and modulating glutathione metabolizing enzymes—An in vitro study

(2010) P.V. Kiruthiga et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Improvement of inflammatory and toxic stress biomarkers by silymarin in a murine model of type one diabetes mellitus

(2009) Farshad Malihi et al.   Open Life Sciences

Antioxidant and protective effects of silymarin on ischemia and reperfusion injury in the kidney tissues of rats

(2008) Faruk Turgut et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis

(2008)   LANCET

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

The potential protective role of alpha-lipoic acid against acetaminophen-induced hepatic and renal damage

(2007) Ahmed O. Abdel-Zaher et al.   TOXICOLOGY